A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection

NCT ID: NCT06198764

This clinical trial is studying a new treatment approach for infections caused by certain bacteria that are resistant to common antibiotics. The researchers are comparing two treatment options: one...

Recruiting

Phase: PHASE3 Conditions: Mental Health Issue

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT06175780

This clinical trial is studying a new treatment called KY-0118 for patients with locally advanced or metastatic solid tumors, which are types of cancer that have either spread from their original s...

Recruiting

Phase: PHASE1 Conditions: Neoplasms, Neoplasms by Histologic Type

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

NCT ID: NCT04450732

This clinical trial is studying a new treatment called GQ1001 for adult patients with certain types of advanced cancer that are positive for the HER2 protein, which includes HER2-positive breast ca...

Recruiting

Phase: PHASE1 Conditions: HER2-positive Breast Cancer, HER2-Positive Advanced Solid Tumor +2 more

Evaluating Different Doses of Orelabrutinib in MCL

NCT ID: NCT05978739

This clinical trial, called "Evaluating Different Doses of Orelabrutinib in MCL," is studying a new medication, Orelabrutinib, to see how well it works and how safe it is for people with Mantle Cel...

Recruiting

Phase: PHASE2 Conditions: Mantle Cell Lymphoma

JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus

NCT ID: NCT05967520

The clinical trial titled JMKX000189 is looking at a new treatment for people with moderate to severe systemic lupus erythematosus (SLE), a condition where the immune system attacks the body’s own ...

Recruiting

Phase: PHASE2 Conditions: Lupus Erythematosus, Systemic

Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject

NCT ID: NCT05684653

This clinical trial is studying a medication called Orelabrutinib to see how it is processed in the body and its safety for people with liver problems, known as hepatic impairment, as well as healt...

Recruiting

Phase: PHASE1 Conditions: Hepatic Impairment

A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT05181137

This clinical trial is studying a new treatment called SHR0302 for people with moderately to severely active ulcerative colitis, which is a condition that causes inflammation and ulcers in the dige...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

NCT ID: NCT05755048

This clinical trial is studying a new treatment called FS-1502 for patients with a specific type of breast cancer known as HER2-positive, which is locally advanced or has spread to other parts of t...

Recruiting

Phase: PHASE3 Conditions: Breast Cancer

Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation

NCT ID: NCT06015568

This clinical trial is looking at a new treatment option for patients with advanced non-small cell lung cancer (NSCLC) that has specific genetic changes known as EGFR-sensitive mutations. The study...

Not yet recruiting

Phase: PHASE1 Conditions: Non-Small Cell Lung Cancer、EGFR Sensitive Mutation

A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer

NCT ID: NCT05990127

This clinical trial is looking at a new treatment approach for patients with a type of lung cancer called non-small cell lung cancer (NSCLC) that is either locally advanced or has spread to other p...

Not yet recruiting

Phase: PHASE3 Conditions: Locally Advanced or Metastatic NSCLC

ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

NCT ID: NCT04578613

This clinical trial is studying a new treatment called ICP-022 for patients with untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). Researchers want to see how well I...

Recruiting

Phase: PHASE3 Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

NCT ID: NCT05862337

This clinical trial is studying a new treatment for patients with hepatocellular carcinoma (HCC), a type of liver cancer, who are at high risk of their cancer coming back after surgery. The trial i...

Recruiting

Phase: PHASE3 Conditions: Hepatocellular Carcinoma

A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

NCT ID: NCT05851014

This clinical trial is investigating a new treatment for patients with advanced breast cancer that is hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-). ...

Recruiting

Phase: PHASE3 Conditions: Breast Cancer

YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

NCT ID: NCT05767892

This clinical trial is studying a new medication called YK-029A to see how well it works as a first treatment for patients with advanced non-small cell lung cancer (NSCLC) that has a specific genet...

Not yet recruiting

Phase: PHASE3 Conditions: Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

NCT ID: NCT05673538

This clinical trial is studying a new medication called TT-00973-MS, which comes in tablet form, for patients with advanced solid tumors. The main goals of the study are to see how safe the medicat...

Not yet recruiting

Phase: PHASE1 Conditions: Advanced Solid Tumor

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT05042375

This clinical trial is studying a new combination treatment for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has come back or spread. The treatment be...

Recruiting

Phase: PHASE3 Conditions: Non-small Cell Lung Cancer

Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

NCT ID: NCT04995159

This clinical trial is looking at a new treatment option for patients with coronary heart disease (CHD) who are receiving a special type of heart stent called the Lepu® NeoVas™ Bioabsorbable Stent....

Not yet recruiting

Phase: NA Conditions: Coronary Heart Disease

A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

NCT ID: NCT04237805

This clinical trial is studying a new treatment called SAF-189s for patients with advanced non-small cell lung cancer (NSCLC), which is a type of lung cancer that has spread and is difficult to tre...

Recruiting

Phase: PHASE1 Conditions: Advanced Cancer, Advanced Solid Tumor +1 more

Chinese Research Group of Gallbladder Cancer

NCT ID: NCT04140552

The Chinese Research Group of Gallbladder Cancer (CRGGC) is conducting a study to gather information about patients diagnosed with gallbladder cancer. This trial is looking at electronic medical re...

Recruiting

Conditions: Gallbladder Neoplasms

HANGZHOU Solution in Bicuspid AS Undergoing TAVR

NCT ID: NCT04722796

The HANGZHOU clinical trial is studying two different methods for placing a heart valve in patients with a specific heart condition called bicuspid aortic stenosis. This condition occurs when the a...

Recruiting

Phase: NA Conditions: Aortic Stenosis, Aortic Stenosis With Bicuspid Valve

Main Menu

Clinical Trials in Bengbu, Anhui

100 Active Trials Found in Bengbu

A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Evaluating Different Doses of Orelabrutinib in MCL

JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus

Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject

A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation

A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer

ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

Chinese Research Group of Gallbladder Cancer

HANGZHOU Solution in Bicuspid AS Undergoing TAVR